- A dictionary of medical eponyms

Michael Somogyi

Born  1883
Died  1971

Related eponyms

Hungarian-American biochemist, born March 7, 1883, Zsámánd, Hungary (now Reinersdorf, Austria); died 1971.

Biography of Michael Somogyi

Michael Somogyi was born in the Hungarian village Zsámánd, in what was then the Empire of Austria-Hungary. This region of Hungary, known in German as the Burgenland, was given to Austria after World War I without plebiscite. The name of the village is now Reinersdorf.

Somogyi graduated in chemistry from the University of Budapest in 1905 and then went to America. At first he had trouble finding suitable work, but eventually he obtained a position as assistant of biochemistry at the Cornell University Medical College, New York:, where he was active until 1908. That year Somogyi returned to Budapest to become chief chemist at the municipal laboratory. He obtained a doctorate from the University of Budapest in 1914.

graduated in chemistry from the University of Budapest in 1905 and then went to America. At first he had trouble finding suitable work, but eventually he obtained a position as assistant of biochemistry at the Cornell University Medical College, New York:, where he was active until 1908. That year Somogyi returned to Budapest to become chief chemist at the municipal laboratory. He obtained a doctorate from the University of Budapest in 1914.

In 1922 his colleague, P. A. Schaffer at the Cornell University, persuaded him to return to the USA to become teacher of biochemistry at the Washington University's medical school in St. Louis. In 1926 he became first chemist at the Jewish Hospital, St. Louis.

In 1926, his first year working as a clinical chemist in St. Louis, he introduced a method for determining reducing sugars in human blood. He took a special interest in diabetic patients and in 1938, at a meeting of the medical society in St. Louis to the theme of “unstable, severe diabetic patients”, Somogyi first presented his theory that insulin treatment in itself might cause unstable diabetes. In 1940 he developed a method for the determination of serum amylase in healthy and diabetic individuals. He is also credited with devising a test for acute pancreatitis.

Somogyi was active at the Jewish Hospital, St. Louis, until his retirement in 1957. He died from a stroke on July 21, 1971.

The first insulin treatment of a child with diabetes in the USA, in October 1922, was done with a preparation of insulin produced by Somogyi.

    “Overtreatment with insulin makes unstable diabetes”.
    Michael Somogyi

    "The incidence of diabetes has increased proportionately with the per capita consumption of sugar."
    (Frederick Grant Banting, Strength and Health Magazine, 1972.)

We thank Bryan Dawson for information submitted.

Bibliography

  • Studies of arteriovenous differences in blood sugar; II. Effect of hypoglycemia on the rate of extrahepatic glucose assimilation.
    Journal of Biological Chemistry, Baltimore, 1948, 174: 597-604.
  • Effect of insulin hypoglycemia on alimentary hyperglycemia.
    Journal of Biological Chemistry, Baltimore, 1951, 193: 859-863.
  • Quantitative relationship between insulin dosage and the amount of carbohydrates utilized in the diabetic persons.
    American Journal of Medicine, 1959.
  • Exacerbation of diabetes by excess insulin action.
    American Journal of Medicine, 1959.
  • Diabetogenic effect of hyperinsulinism. American Journal of Medicine, 1959.

What is an eponym?

An eponym is a word derived from the name of a person, whether real or fictional. A medical eponym is thus any word related to medicine, whose name is derived from a person.

What is Whonamedit?

Whonamedit.com is a biographical dictionary of medical eponyms. It is our ambition to present a complete survey of all medical phenomena named for a person, with a biography of that person.

Disclaimer:

Whonamedit? does not give medical advice.
This survey of medical eponyms and the persons behind them is meant as a general interest site only. No information found here must under any circumstances be used for medical purposes, diagnostically, therapeutically or otherwise. If you, or anybody close to you, is affected, or believe to be affected, by any condition mentioned here: see a doctor.